Quantitative phase imaging of platelet: assessment of cell morphology and function

It is well known that platelets play a central role in hemostasis and thrombosis, they also mediate tumor cell growth, dissemination and angiogenesis. The purpose of the present experiment was to evaluate living platelet size, function and morphology simultaneously in unactivated and activated states using Phase-Interference Microscope “Cytoscan” (Moscow, Russia). We enrolled 30 healthy volunteers, who had no past history of aeteriosclerosis-related disorders, such as coronary heart disease, cerebrovascular disease, hypertention, diabetes or hyperlipidemia and 30 patients with oropharynx cancer. We observed the optic-geometrical parameters of each isolated living cell and the distribution of platelets by sizes have been analysed to detect the dynamics of cell population heterogeneity. Simultaneously we identified 4 platelet forms that have different morphological features and different parameters of size distribution. We noticed that morphological platelet types correlate with morphometric platelet parameters. The data of polymorphisms of platelet reactivity in tumor progression can be used to improve patient outcomes in the cancer prevention and treatment. Moreover morphometric and functional platelet parameters can serve criteria of the efficiency of the radio- and chemotherapy carried out. In conclusion the computer phase-interference microscope provides rapid and effective analysis of living platelet morphology and function at the same time. The use of the computer phase-interference microscope could be an easy and fast method to check the state of platelets in patients with changed platelet activation and to follow a possible pharmacological therapy to reduce this phenomenon.

[1]  T. V. D. van de Ven,et al.  Long-range interactions in mammalian platelet aggregation. II. The role of platelet pseudopod number and length. , 1990, Biophysical journal.

[2]  M. Hino,et al.  Clinical significance of simultaneous measurement of reticulated platelets and large platelets in idiopathic thrombocytopenic purpura. , 2000, Haematologia.

[3]  B. Suess,et al.  Pharmacological Inhibition of Platelet-Tumor Cell Cross-Talk Prevents Platelet-Induced Overexpression of Cyclooxygenase-2 in HT29 Human Colon Carcinoma Cells , 2013, Molecular Pharmacology.

[4]  R. Abbate,et al.  Platelet function tests: a comparative review , 2015, Vascular health and risk management.

[5]  S. Choi,et al.  Mean platelet volume in Korean patients with acute ischemic stroke: A gender difference , 2013, Platelets.

[6]  V. P. Tychinskii,et al.  Coherent phase microscopy of intracellular processes , 2001 .

[7]  R. Hynes,et al.  Abstract PR1: Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis , 2011 .

[8]  Cynthia S. Johnson,et al.  Prognostic factors in stage III non-small-cell lung cancer. , 2007, Clinical Lung Cancer.

[9]  John F. Martin,et al.  A role for changes in platelet production in the cause of acute coronary syndromes. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[10]  S. Watson Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. , 2009, Current pharmaceutical design.

[11]  Laurie J. Gay,et al.  Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.

[12]  G. Lip,et al.  The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood , 2008, Journal of Thrombosis and Thrombolysis.

[13]  M. Lishner,et al.  Are platelet volume indices of clinical use? A multidisciplinary review , 2012, Annals of medicine.

[14]  P. Noris,et al.  Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia , 2009, Journal of thrombosis and haemostasis : JTH.

[15]  Heesang Song,et al.  Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease , 2016, The Korean journal of internal medicine.

[16]  Deepak L. Bhatt,et al.  Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis , 2010, Journal of thrombosis and haemostasis : JTH.

[17]  E. Abel,et al.  Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. , 2000, Platelets.

[18]  K. Jurk,et al.  Platelets: Physiology and Biochemistry , 2005, Seminars in thrombosis and hemostasis.

[19]  O. Guntinas-Lichius,et al.  Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients , 2012, Journal of Cancer Research and Clinical Oncology.

[20]  M. Rusak,et al.  Platelet activation in patients with advanced gastric cancer. , 2010, Neoplasma.

[21]  G. Kitas,et al.  Mean platelet volume: a link between thrombosis and inflammation? , 2011, Current pharmaceutical design.

[22]  Marianne Paesmans,et al.  Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables , 2011, Therapeutic advances in medical oncology.

[23]  S. Goodman,et al.  Platelet interaction with pyrolytic carbon heart-valve leaflets. , 1996, Journal of biomedical materials research.

[24]  G. FitzGerald,et al.  Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells , 2016, Oncotarget.